DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Triapine is an investigational drug.
There have been 32 clinical trials for Triapine. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2003.
The most common disease conditions in clinical trials are Adenocarcinoma, Uterine Cervical Neoplasms, and Leukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Vion Pharmaceuticals, and University Health Network, Toronto.
Recent Clinical Trials for Triapine
|Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy||National Cancer Institute (NCI)||Early Phase 1|
|Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors||National Cancer Institute (NCI)||Phase 1|
|Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer||National Cancer Institute (NCI)||Phase 1|